Skip to main content
Article thumbnail
Location of Repository

A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study

By X. Chevalier, P. Ravaud, E. Maheu, G. Baron, A. Rialland, P. Vergnaud, C. Roux, Y. Maugars, D. Mulleman, C. Lukas, D. Wendling, P. Laforgue, Damien Loeuille, V. Foltz and P. Richette


RésuméInternational audienc

Topics: [ SDV.BBM.BC ] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM], [ SDV.BBM.BM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, [ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology
Publisher: HAL CCSD
Year: 2013
OAI identifier: oai:HAL:hal-01509629v1
Provided by: Hal-Diderot
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.